Katherine Bonter – Biography
Last update: March 25, 2026Executive profile
Katherine was Director of Clinical Sciences at Ipsen, and Director of Intellectual Property at Clementia Pharmaceuticals. Katherine Bonter joined Congruence Therapeutics in 2022.
Katherine Bonter is currentlyExecutive Director of Intellectual Property at Congruence Therapeutics - View - Congruence Therapeutics org chart
Create your alert
to follow the career of Katherine Bonter.
Education
Katherine Bonter has a Master of Science in Neurosicence from Université Concordia in 1997 and a Doctor of Philosophy in Innovation Policy from McGill University in 2020.
They have also studied at McGill University :
Find more alumni from McGill University
More about Katherine Bonter
Selected links
Do you need to know more about Katherine Bonter? More results.
Participate
Social media
- Katherine Bonter on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Katherine Bonter
The colleagues of Katherine Bonter
Company Colleagues
- At Congruence Therapeutics, Katherine Bonter has 20 colleagues including Clarissa Desjardins (CEO), Nancy Harrison (Director)…
Industry Colleagues
- In the Biotechnology industry, Katherine Bonter has 35,763 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Katherine Bonter.
Get in Touch
Here are a few tips for establishing great contacts.
